Clearside Biomedical Faces Nasdaq Delisting After Bankruptcy Filing
I'm PortAI, I can summarize articles.
Clearside Biomedical Inc. faces Nasdaq delisting after filing for Chapter 11 bankruptcy. Trading was suspended on December 1, 2025, and the company filed a Form 25 with the SEC to deregister its shares. The stock now trades on the OTC Pink Limited Market, reducing SEC reporting obligations. This news was generated by Public Technologies using AI and is not financial advice.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments